Decipher Labs Reports Negative Performance in Q2, Receives 'Strong Sell' Rating
Decipher Labs, a microcap pharmaceutical company, reported a negative performance in the second quarter of fiscal year 2024-2025. Net sales and profit after tax have decreased by 21.63% and 21.71% respectively, with a negative trend in the near-term. The company's stock has been given a 'Strong Sell' rating, highlighting a negative outlook for investors.
Decipher Labs, a microcap pharmaceutical company, recently announced its financial results for the quarter ending September 2024. The company's stock has been given a 'Strong Sell' rating by MarketsMOJO.
According to the financial report, Decipher Labs has seen a negative performance in the second quarter of the fiscal year 2024-2025. The company's score has fallen from 11 to -9 in the last three months.
One of the major factors contributing to this decline is the decrease in net sales, which have fallen by 21.63% year on year. The company's near-term sales trend is also showing a negative trend. Similarly, the profit after tax (PAT) for the half-yearly period has also decreased by 21.71% year on year. The near-term trend for PAT is also negative.
In addition, Decipher Labs has recorded its lowest net sales in the last five quarters, at Rs 5.87 crore. This further highlights the negative sales trend for the company. The cash and cash equivalents for the half-yearly period have also decreased, reaching its lowest point at Rs 4.93 crore in the last six half-yearly periods. This indicates a deteriorating short-term liquidity for the company.
Overall, the financial results for the quarter ending September 2024 have not been favorable for Decipher Labs. The company's stock has been given a 'Strong Sell' rating by MarketsMOJO, indicating a negative outlook for investors.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
